Clinical Trial Update: JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases [Phase 1]

View source ↗

Summary

This clinical trial update outlines the Phase 1 study JWCAR201 for hematology malignancies and autoimmune diseases, which is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• B-cell Lymphoma
• Hematologic Malignancies
• Large B-cell Lymphoma
• Systemic Lupus Erythematosus

Snippet

Sponsor: RenJi Hospital | Conditions: B-cell Tumors, Autoimmune Diseases | Phase 1 | Status: NOT_YET_RECRUITING